The molecular architecture of the TNF superfamily

Trends in Biochemical Sciences

Volumn 27, Issue 1, 2002, Pages 19-26

  Bodmer, Jean Luc ^a   Schneider, Pascal ^a   Tschopp, Jürg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CYSTEINE; EPIDERMAL GROWTH FACTOR; LIGAND; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID SEQUENCE; CONFORMATIONAL TRANSITION; EXPRESSED SEQUENCE TAG; GENETIC DISORDER; GENETIC HETEROGENEITY; HUMAN; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; VIRUS CAPSID;

AMINO ACID SEQUENCE; LIGANDS; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; PROTEIN FOLDING; RECEPTORS, TUMOR NECROSIS FACTOR; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR NECROSIS FACTOR-ALPHA;

MIRIDAE;

EID: 0036162436     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(01)01995-8     Document Type: Review

References (53)

1. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
2. Evidence for a role of a tumor necrosis factor-α (TNF-α)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival
3. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis
4. Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia
5. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth
6. Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A
7. Downregulation of Fas ligand by shedding
8. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors
9. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage
10. The TNF and TNF receptor superfamilies: Integrating mammalian biology
11. Development and maturation of secondary lymphoid tissues
12. CD40 and its crucial role as a member of the TNFR family
13. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
14. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
15. Tumor necrosis factor receptor family members in the immune system
16. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
17. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
18. CD95's deadly mission in the immune system
19. Proinflammatory cytokines
20. The structure of tumor necrosis factor-α at 2.6 Å resolution. Implications for receptor binding
21. Structure of tumour necrosis factor
22. Crystal structure of the soluble human 55 kd TNF receptor-human TNF β complex: Implications for TNF receptor activation
23. 2 Å crystal structure of an extracellular fragment of human CD40 ligand
24. Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity
25. Triggering cell death: The crystal structure of Apo2L/TRAIL in a complex with death receptor 5
26. A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL
27. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation
28. Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL
29. Functional analysis of tumour necrosis factor-α-related apoptosis-inducing ligand (TRAIL): Cysteine-230 plays a critical role in the homotrimerization and biological activity of this novel tumoricidal cytokine
30. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
31. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor
32. C1q: Structure, function, and receptors
33. AdipoQ is a novel adipose-specific gene dysregulated in obesity
34. A novel serum protein similar to C1q, produced exclusively in adipocytes
35. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weightloss in mice
36. Three-dimensional structure of poliovirus at 2.9 Å resolution
37. Cell recognition and entry by rhino- and enteroviruses
38. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas
39. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
40. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes
41. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
42. Neurotrophin receptor structure and interactions
43. Modularity in the TNF-receptor family
44. BAFF-R, a novel TNF receptor that specifically interacts with BAFF
45. Structures of the extracellular domain of the type I tumor necrosis factor receptor
46. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
47. Laminins: Structure and genetic regulation
48. Crystal structure of three consecutive laminin-type epidermal growth factor-like (LE) modules of laminin γ1 chain harboring the nidogen binding site
49. Structural basis for self-association and receptor recognition of human TRAF2
50. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors
51. Herpes simplex virus glycoprotein D bound to the human receptor HveA
52. Protein modelling for all
53. Identification of a ligand for the death-domain-containing receptor Apo3